Hjem
Ottar Kjell Nygårds bilde

Ottar Kjell Nygård

Professor
  • E-postOttar.Nygard@uib.no
  • Telefon+47 55 97 30 64
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2022). Within-person reproducibility of proteoforms related to inflammation and renal dysfunction. Scientific Reports. 9 sider.
  • Vis forfatter(e) (2022). The association between dairy intake and risk of cardiovascular disease and mortality in patients with stable angina pectoris. European Journal of Preventive Cardiology (EJPC). 219-229.
  • Vis forfatter(e) (2022). Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment. International Journal of Cardiology: Cardiovascular Risk and Prevention (IJCCRP). 6 sider.
  • Vis forfatter(e) (2022). Even chained acylcarnitines predict long-term cardiovascular prognosis in patients with chest pain and non-obstructive coronary artery disease. International Journal of Cardiology: Cardiovascular Risk and Prevention (IJCCRP). 8 sider.
  • Vis forfatter(e) (2022). Comparison of nutritional risk screening with NRS2002 and the GLIM diagnostic criteria for malnutrition in hospitalized patients. Scientific Reports. 9 sider.
  • Vis forfatter(e) (2022). Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease. Journal of Internal Medicine. 915-924.
  • Vis forfatter(e) (2021). Trimethyllysine predicts all-cause and cardiovascular mortality in community-dwelling adults and patients with coronary heart disease. European Heart Journal Open (EHJ Open). 10 sider.
  • Vis forfatter(e) (2021). Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 10 sider.
  • Vis forfatter(e) (2021). Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: The WESTCOR study. European Heart Journal: Acute Cardiovascular Care. 287-301.
  • Vis forfatter(e) (2019). Hypertensive pregnancy disorders increase the risk of maternal cardiovascular disease after adjustment for cardiovascular risk factors. International Journal of Cardiology. 81-87.
  • Vis forfatter(e) (2019). Elevated plasma cystathionine is associated with increased risk of mortality among patients with suspected or established coronary heart disease. American Journal of Clinical Nutrition. 1546-1554.
  • Vis forfatter(e) (2018). Usefulness of higher levels of cardiac troponin T in patients with stable angina pectoris to predict risk of acute myocardial infarction. American Journal of Cardiology. 1142-1147.
  • Vis forfatter(e) (2018). Serum carnitine metabolites and incident type 2 diabetes mellitus in patients with suspected stable angina pectoris. Journal of Clinical Endocrinology and Metabolism (JCEM). 1033-1041.
  • Vis forfatter(e) (2018). Plasma cystathionine and risk of incident stroke in patients with suspected stable angina pectoris. Journal of the American Heart Association (JAHA). 12 sider.
  • Vis forfatter(e) (2018). Plasma choline, homocysteine and vitamin status in healthy adults supplemented with krill oil: a pilot study. Scandinavian Journal of Clinical and Laboratory Investigation. 1-7.
  • Vis forfatter(e) (2018). Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris. Journal of Clinical Endocrinology and Metabolism (JCEM). 1161-1170.
  • Vis forfatter(e) (2018). Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans. The FASEB Journal. 6019-6024.
  • Vis forfatter(e) (2018). Antibodies to receptors are associated with biomarkers of inflammation and myocardial damage in heart failure. International Journal of Cardiology. 253-259.
  • Vis forfatter(e) (2017). Visceral adiposity and metabolic syndrome after very high-fat and low-fat isocaloric diets: A randomized controlled trial. American Journal of Clinical Nutrition. 85-99.
  • Vis forfatter(e) (2017). Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: A Cardiovascular Disease in Norway project. European Journal of Preventive Cardiology (EJPC). 971-980.
  • Vis forfatter(e) (2017). Time trends and educational inequalities in out-of-hospital coronary deaths in Norway 1995-2009: A Cardiovascular Disease in Norway (CVDNOR) project. Journal of the American Heart Association (JAHA). 8 sider.
  • Vis forfatter(e) (2017). The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease. Diabetologia. 1712-1721.
  • Vis forfatter(e) (2017). Smoking, plasma cotinine and risk of atrial fibrillation: the Hordaland Health Study. Journal of Internal Medicine. 73-82.
  • Vis forfatter(e) (2017). Serum acylcarnitines and risk of cardiovascular death and acute myocardial infarction in patients with stable angina pectoris. Journal of the American Heart Association (JAHA). 1-28.
  • Vis forfatter(e) (2017). Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. The Lancet Diabetes and Endocrinology. 534-543.
  • Vis forfatter(e) (2017). Ratios of one-carbon metabolites are functional markers of B-vitamin status in a Norwegian coronary angiography screening cohort. Journal of Nutrition. 1167-1173.
  • Vis forfatter(e) (2017). Prognostic impact of in-hospital and postdischarge heart failure in patients with acute myocardial infarction: a nationwide analysis using data from the Cardiovascular Disease in Norway (CVDNOR) Project. Journal of the American Heart Association (JAHA). 17 sider.
  • Vis forfatter(e) (2017). Neopterin as an effect modifier of the cardiovascular risk predicted by total homocysteine: A prospective 2-cohort study. Journal of the American Heart Association (JAHA). 1-17.
  • Vis forfatter(e) (2017). Metabolomic evaluation of the consequences of plasma cystathionine elevation in adults with stable angina pectoris. Journal of Nutrition. 1658-1668.
  • Vis forfatter(e) (2017). Incident coronary heart disease after Preeclampsia: Role of reduced fetal growth, preterm delivery, and parity. Journal of the American Heart Association (JAHA). 13 sider.
  • Vis forfatter(e) (2017). Dietary choline intake is directly associated with bone mineral density in the Hordaland Health Study. Journal of Nutrition. 572-578.
  • Vis forfatter(e) (2017). Cardiovascular disease risk associated with serum apolipoprotein B is modified by serum vitamin A. Atherosclerosis. 325-330.
  • Vis forfatter(e) (2017). B Vitamins and Hip Fracture: Secondary Analyses and Extended Follow-Up of Two Large Randomized Controlled Trials. Journal of Bone and Mineral Research. 1981-1989.
  • Vis forfatter(e) (2017). Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease. European Journal of Nutrition. 261-272.
  • Vis forfatter(e) (2017). Associations between fish intake and the metabolic syndrome and its components among middle-aged men and women: the Hordaland Health Study. Food & Nutrition Research (FNR). 11 sider.
  • Vis forfatter(e) (2016). Vitamin B-6 catabolism and long-term mortality risk in patients with coronary artery disease. American Journal of Clinical Nutrition. 1417-1425.
  • Vis forfatter(e) (2016). The universal 2012 definition of myocardial infarction compared to the 2007 definition. Scandinavian Cardiovascular Journal. 201-205.
  • Vis forfatter(e) (2016). The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia. Journal of Hypertension. 132-139.
  • Vis forfatter(e) (2016). Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice. Lipids in Health and Disease. 16 sider.
  • Vis forfatter(e) (2016). Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study. Lipids in Health and Disease.
  • Vis forfatter(e) (2016). Prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes. Clinical Chemistry. 755-765.
  • Vis forfatter(e) (2016). Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris. Journal of the American Heart Association (JAHA). 9 sider.
  • Vis forfatter(e) (2016). Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. European Heart Journal. 1967-1976.
  • Vis forfatter(e) (2016). Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study. American Journal of Epidemiology. 249-258.
  • Vis forfatter(e) (2016). Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats. Nutrients.
  • Vis forfatter(e) (2016). Methylenetetrahydrofolate dehydrogenase 1 polymorphisms modify the associations of plasma glycine and serine with risk of acute myocardial infarction in patients with stable angina pectoris in WENBIT (Western Norway B Vitamin Intervention Trial). Circulation: Cardiovascular Genetics. 541-547.
  • Vis forfatter(e) (2016). Higher education is associated with reduced risk of heart failure among patients with acute myocardial infarction: A nationwide analysis using data from the CVDNOR project. European Journal of Preventive Cardiology (EJPC). 1743-1750.
  • Vis forfatter(e) (2016). Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project. Journal of the American Heart Association (JAHA). 8 sider.
  • Vis forfatter(e) (2016). Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease . New England Journal of Medicine. 1242-1252.
  • Vis forfatter(e) (2016). Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway. European Journal of Clinical Nutrition. 517-522.
  • Vis forfatter(e) (2016). Coronary angiography and myocardial revascularization following the first acute myocardial infarction in Norway during 2001-2009: Analyzing time trends and educational inequalities using data from the CVDNOR project. International Journal of Cardiology. 122-128.
  • Vis forfatter(e) (2016). Circulating folate and vitamin B12 and risk of prostate cancer: a collaborative analysis of individual participant data from six cohorts including 6875 cases and 8104 controls. European Urology. 941-951.
  • Vis forfatter(e) (2016). B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 495-501.
  • Vis forfatter(e) (2016). Association between weight change and mortality in community living older people followed for up to 14 years. The Hordaland Health Study (HUSK). The Journal of Nutrition, Health & Aging. 909-917.
  • Vis forfatter(e) (2016). Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris. PLOS ONE.
  • Vis forfatter(e) (2015). Vitamin D status was not associated with 'one-year' progression of coronary artery disease, assessed by coronary angiography in statin-treated patients. European Journal of Preventive Cardiology (EJPC). 594-602.
  • Vis forfatter(e) (2015). Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment: an observational study using propensity score matching. PLOS ONE. 13 sider.
  • Vis forfatter(e) (2015). Trends in 28-day and 1-year mortality rates in patients hospitalized for a first acute myocardial infarction in Norway during 2001-2009: A Cardiovascular disease in Norway (CVDNOR) project. Journal of Internal Medicine. 353-361.
  • Vis forfatter(e) (2015). Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. Journal of Hypertension. 2294-2302.
  • Vis forfatter(e) (2015). Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Osteoporosis International. 1573-1583.
  • Vis forfatter(e) (2015). Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. European Journal of Preventive Cardiology (EJPC). 606-614.
  • Vis forfatter(e) (2015). Novel inflammatory biomarkers in primary hyperparathyroidism. European Journal of Endocrinology (EJE). 9-17.
  • Vis forfatter(e) (2015). Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway. European Journal of Preventive Cardiology (EJPC). 872-881.
  • Vis forfatter(e) (2015). Markers of vitamin B6 status and metabolism as predictors of incident cancer: The Hordaland Health Study. International Journal of Cancer. 2932-2939.
  • Vis forfatter(e) (2015). Kynurenines as predictors of acute coronary events in the Hordaland Health Study. International Journal of Cardiology. 18-24.
  • Vis forfatter(e) (2015). Hypertriglyceridemic-Waist Phenotype is a Useful Global Assessment Tool for Predicting Acute Myocardial Infarction. Journal of Cardiovascular Diseases & Diagnosis. 1-6.
  • Vis forfatter(e) (2015). Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study. Atherosclerosis. 115-120.
  • Vis forfatter(e) (2015). Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. European Journal of Preventive Cardiology (EJPC). 743-752.
  • Vis forfatter(e) (2015). Effect of the Lookback period's length used to identify incident acute myocardial infarction on the observed trends on incidence rates and survival: cardiovascular disease in Norway project. Circulation. Cardiovascular Quality and Outcomes. 376-382.
  • Vis forfatter(e) (2015). Dietary intake of saturated fat is not associated with risk of coronary events or mortality in patients with established coronary artery disease. Journal of Nutrition. 299-305.
  • Vis forfatter(e) (2015). Clinical significance of late enhancement and regional wall remodeling assessed by 3T magnetic resonance imaging. Clinical Medicine Insights: Cardiology. 17-24.
  • Vis forfatter(e) (2015). Circulating B-vitamins and smoking habits are associated with serum polyunsaturated fatty acids in patients with suspected coronary heart disease: A cross-sectional study. PLOS ONE. 14 sider.
  • Vis forfatter(e) (2015). Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. Arteriosclerosis, Thrombosis and Vascular Biology. 455-462.
  • Vis forfatter(e) (2015). A water-soluble extract of chicken reduced plasma triacylglycerols, but showed no anti-atherosclerotic activity in apoE<sup>-/-</sup> mice. Journal of Nutrition and Intermediary Metabolism. 8-14.
  • Vis forfatter(e) (2015). A protein extract from chicken reduces plasma homocysteine in rats. Nutrients. 4498-4511.
  • Vis forfatter(e) (2015). A Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats. Mar. Drugs. Marine Drugs. 5706-5721.
  • Vis forfatter(e) (2014). Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-gamma-mediated immune activation in the community-based Hordaland health study. British Journal of Nutrition. 1065-1072.
  • Vis forfatter(e) (2014). Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a cardiovascular disease in Norway project). American Journal of Cardiology. 1777-1781.
  • Vis forfatter(e) (2014). Smoking and body fat mass in relation to bone mineral density and hip fracture: The Hordaland Health Study. PLOS ONE. 9 sider.
  • Vis forfatter(e) (2014). Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Annals of Oncology. 1609-1615.
  • Vis forfatter(e) (2014). Plasma choline, nicotine exposure, and risk of low bone mineral density and hip fracture: the Hordaland Health Study. Journal of Bone and Mineral Research. 242-250.
  • Vis forfatter(e) (2014). Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients. Journal of Nutrition. 784-790.
  • Vis forfatter(e) (2014). Interferon-γ-induced inflammatory markers and the risk of cancer: The Hordaland Health Study. Cancer. 3370-3377.
  • Vis forfatter(e) (2014). Interactions between plasma concentrations of folate and markers of vitamin B12 status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study. British Journal of Nutrition. 1085-1095.
  • Vis forfatter(e) (2014). Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • Vis forfatter(e) (2014). Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism. European Journal of Nutrition. 193-204.
  • Vis forfatter(e) (2014). High consumption of farmed salmon does not disrupt the steady state of persistent organic pollutants (POP) in human plasma and adipose tissue. Journal of Toxicology and Environmental Health, Part A. 1229-1250.
  • Vis forfatter(e) (2014). Evidence for increased catabolism of vitamin B-6 during systemic inflammation. American Journal of Clinical Nutrition. 250-255.
  • Vis forfatter(e) (2014). Educational inequalities in acute myocardial infarction incidence in Norway: A nationwide cohort study. PLOS ONE. 8 sider.
  • Vis forfatter(e) (2014). Educational inequalities in 28 day and 1-year mortality after hospitalisation for incident acute myocardial infarction - A nationwide cohort study. International Journal of Cardiology. 874-880.
  • Vis forfatter(e) (2014). Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: A prospective cohort study. BMC Cardiovascular Disorders.
  • Vis forfatter(e) (2013). Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. American Journal of Clinical Nutrition. 934-940.
  • Vis forfatter(e) (2013). Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2. Prostaglandins, Leukotrienes and Essential Fatty Acids. 297-303.
  • Vis forfatter(e) (2013). Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. International Journal of Cardiology. 1435-1440.
  • Vis forfatter(e) (2013). Associations between plasma polyunsaturated fatty acids, plasma stearoyl-CoA desaturase indices and body fat. Obesity. E512-E519.
  • Vis forfatter(e) (2013). An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoE(-/-) mice. PLOS ONE. 14 sider.
  • Vis forfatter(e) (2012). Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. Cardiology Research and Practice. 11 sider.
  • Vis forfatter(e) (2011). Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. Journal of Nutrition. 611-617.
  • Vis forfatter(e) (2011). Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12. Coronary Artery Disease. 270-278.
  • Vis forfatter(e) (2011). Cobalamin Status Modifies the Effect of Zinc Supplementation on the Incidence of Prolonged Diarrhea in 6-to 30-Month-Old North Indian Children. Journal of Nutrition. 1108-1113.
  • Vis forfatter(e) (2010). Systemic Markers of Interferon-–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease. Arteriosclerosis, Thrombosis and Vascular Biology.
  • Vis forfatter(e) (2010). Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. Clinical Chemistry. 755-763.
  • Vis forfatter(e) (2010). Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. American Journal of Clinical Nutrition. 244-251.
  • Vis forfatter(e) (2010). Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. Journal of Internal Medicine. 367-382.
  • Vis forfatter(e) (2009). Short-term and long-term case fatality in 11 878 patients hospitalized with a first acute myocardial infarction, 1979-2001: the Western Norway cardiovascular registry. European Journal of Cardiovascular Prevention & Rehabilitation. 621-627.
  • Vis forfatter(e) (2009). Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. Echocardiography. 52-60.
  • Vis forfatter(e) (2009). Cancer incidence and mortality after treatment with folic acid and vitamin B12. Journal of the American Medical Association (JAMA). 2119-2126.
  • Vis forfatter(e) (2008). Sykehusinnleggelser for hjerte- og karsykdom i Helse Vest i perioden 1992-2001. Tidsskrift for Den norske legeforening. 17-23.
  • Vis forfatter(e) (2008). Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. Journal of the American Medical Association (JAMA). 795-804.
  • Vis forfatter(e) (2008). Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? American Journal of Clinical Nutrition. 738-746.
  • Vis forfatter(e) (2008). Factor structure of the revised Jalowiec Coping Scale in patients admitted for elective coronary angiography*. Scandinavian Journal of Caring Sciences. 596-607.
  • Vis forfatter(e) (2008). Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. Journal of Nutrition. 914-920.
  • Vis forfatter(e) (2008). Comparison of the Short Form 36 and the Hospital Anxiety and Depression Scale measuring emotional distress in patients admitted for elective coronary angiography. Heart & Lung. 286-295.
  • Vis forfatter(e) (2008). Associations between disease severity, coping and dimensions of health-related quality of life in patients admitted for elective coronary angiography - a cross sectional study. Health and Quality of Life Outcomes. 12 sider.
  • Vis forfatter(e) (2007). Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 514-521.
  • Vis forfatter(e) (2007). Plasma creatinine as a determinant of plasma total homocysteine concentrations in the Hordaland Homocysteine Study: Use of statistical modeling to determine reference limits. Clinical Biochemistry. 1209-1218.
  • Vis forfatter(e) (2007). Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. Journal of Internal Medicine. 244-253.
  • Vis forfatter(e) (2007). Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. American Journal of Clinical Nutrition. 1470-1478.
  • Vis forfatter(e) (2006). The hordaland homocysteine study: A community-based study of homocysteine, its determinants, and associations with disease. Journal of Nutrition. 1731-1740.
  • Vis forfatter(e) (2006). Relationship between provider-based measures of physical function and self-reported health-related quality of life in patients admitted for elective coronary angiography. Heart & Lung. 11 sider.
  • Vis forfatter(e) (2006). Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. American Heart Journal. 282-287.
  • Vis forfatter(e) (2006). Effect of vitamin B-12 treatment on haptocorrin. Clinical Chemistry. 1104-1111.
  • Vis forfatter(e) (2005). Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. European Journal of Clinical Nutrition. 480-488.
  • Vis forfatter(e) (2004). Changes in lifestyle and plasma total homocysteine. The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 812-819.
  • Vis forfatter(e) (2002). Plasma total homocysteine and hospitalizations for cardiovascular disease: The Hordaland Homocysteine Study. Archives of Internal Medicine. 1374-1381.
  • Vis forfatter(e) (2001). Plasma total homocysteine is influenced by prandial status in humans: The Hordaland Homocysteine Study. Journal of Nutrition. 1214-1216.
  • Vis forfatter(e) (1999). Apolipoprotein A1 and risk for coronary artery disease. Scandinavian Cardiovascular Journal. 19.
  • Vis forfatter(e) (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Vis forfatter(e) (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Vis forfatter(e) (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Vis forfatter(e) (1998). Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism: Clinical and Experimental. 89-93.
  • Vis forfatter(e) (1998). Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study [see comments]. American Journal of Clinical Nutrition. 263-270.
  • Vis forfatter(e) (1998). Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 263-270.
  • Vis forfatter(e) (1998). Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • Vis forfatter(e) (1998). Homocysteine and cardiovascular disease. Annual Review of Medicine. 31-62.
  • Vis forfatter(e) (1998). Homocystein og koronarsykdom. Lipid-forum. 17-22.
  • Vis forfatter(e) (1997). Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Vis forfatter(e) (1997). Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Vis forfatter(e) (1997). Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 230-236.
  • Vis forfatter(e) (1997). Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • Vis forfatter(e) (1997). Homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. Norsk Epidemiologi. 221-224.
  • Vis forfatter(e) (1997). Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Vis forfatter(e) (1997). Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Vis forfatter(e) (1997). Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition. 136-143.
  • Vis forfatter(e) (1996). The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • Vis forfatter(e) (1996). The Hordaland homocysteine study: The opposite tails odds ratios (OTOR) reveal differential effects og gender and intake of vitamin supplements at high and low plasma homocysteine concentrations. Journal of Nutrition. 1244S-1248S.
  • Vis forfatter(e) (1996). Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Vis forfatter(e) (1996). Determinants and vitamin responsiveness of the intermediate homohypercysteinemia (> 40 _mmol/L). The Hordaland homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Vis forfatter(e) (1996). Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia (@z _mmol/liter). The Hordaland Homocysteine study. Journal of Clinical Investigation. 2174-2183.
  • Vis forfatter(e) (1995). Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. Journal of the American Medical Association (JAMA). 1526-1533.
  • Vis forfatter(e) (1995). Kolesterolbestemmelse ved sesjon. En måte å identifisere personer med høy risiko for å utvikle hjerte- og karsykdom. Tidsskrift for Den norske legeforening. 3249-3253.
Vitenskapelig foredrag
  • Vis forfatter(e) (2020). Low 3-hydroxyisobutyrate (3-HIB) and high methylmalonic acid (MMA) levels in plasma reflect increased hepatic fatty acid oxidation.
  • Vis forfatter(e) (2018). Using metabolic profiling to explore molecular effects of replacing saturated fat with polyunsaturated fat- a randomized controlled dietary intervention study.
  • Vis forfatter(e) (2017). Association between dietary fat intake and coronary heart disease in middle-age adults. The Hordaland Health Study (HUSK) .
  • Vis forfatter(e) (2015). Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.
  • Vis forfatter(e) (2014). VITAMIN D STATUS AND MORTALITY IN PATIENTS WITH STABLE ANGINA.
  • Vis forfatter(e) (2013). Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi.
  • Vis forfatter(e) (2012). Intake of saturated fat is and risk of coronary events in patients with suspected heart disease.
  • Vis forfatter(e) (2010). Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
  • Vis forfatter(e) (2007). WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007.
  • Vis forfatter(e) (2007). WENBIT - Western Norway B-vitamin intervention trial.
  • Vis forfatter(e) (2007). Total homocysteine, systemic markers of inflammation and long-term mortality in patients with stable angina.
  • Vis forfatter(e) (2007). Components of the metabolic syndrome and other cardiovascular risk factors as predictors of plasma choline and betaine.
  • Vis forfatter(e) (2007). Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in patients with stable angina.
  • Vis forfatter(e) (2002). Total homocysteine levels predicts major coronary events and mortaliy in simvastatin treated patients of 4S.
  • Vis forfatter(e) (2001). Total homocysteine predicts mortality and major coronary events also in simvastatin treated patients of 4S.
  • Vis forfatter(e) (2001). Total homocysteine predicts major coronary events and mortality in simvastatin treated patients of 4S.
  • Vis forfatter(e) (2001). Total Homocysteine Levels Predicts Major Coronary Events and Mortality in Simvastatin Treated Patients of 4S.
  • Vis forfatter(e) (2001). Homocysteine predicts mortality and coronary events in 4S patients.
  • Vis forfatter(e) (1999). Plasma levels of homocysteine are changed during treatment of hyper- and hypothyroidism.
  • Vis forfatter(e) (1999). Apolipoprotein A1 and risk for coronary artery disease.
  • Vis forfatter(e) (1998). Plasma total homocysteine: a risk factor for mortality in aortic stenosis patients.
  • Vis forfatter(e) (1997). Total mortality and serum uric acid in patients with confirmed coronary artery disease.
  • Vis forfatter(e) (1997). Plasma homocysteine predicts mortality in coronary artery diseased patients.
  • Vis forfatter(e) (1997). Plasma homocystein og livsstil. Resultater fra Homocysteinundersøkelsen i Hordaland 1992-1993. [Poster].
  • Vis forfatter(e) (1995). Plasma homocysteine and relation to coffee and tea comsimption.
  • Vis forfatter(e) (1995). Plasma homocystein og forbruk av kaffe og te.
Sammendrag/abstract
  • Vis forfatter(e) (2015). A genetic connection between preeclampsia and chronic hypertension in Norwegian families. Pregnancy Hypertension. 138-139.
  • Vis forfatter(e) (2013). DETERMINANTS OF VITAMIN D STATUS IN PATIENTS WITH STABLE ANGINA. Annals of Nutrition and Metabolism. 241-241.
  • Vis forfatter(e) (2013). Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. Gynekologen. 43-44.
  • Vis forfatter(e) (2012). Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. European Heart Journal. 132-132.
  • Vis forfatter(e) (2012). INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. Placenta. A82-A82.
  • Vis forfatter(e) (2009). Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. European Journal of Cardiovascular Prevention & Rehabilitation. P340-P340.
  • Vis forfatter(e) (2009). Detection of non-viable myocardium by 3T MRI in patients without obstructive coronary artery disease. Cardiology. 88-89.
  • Vis forfatter(e) (2009). Delayed contrast-enhancement and left ventricular remodelling demonstrated at high-field 3T MRI of patients with suspected coronary artery disease. Cardiology. 82-83.
  • Vis forfatter(e) (2008). The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic progression of atherosclerosis in patients with coronary artery disease. Circulation. E345-E346.
  • Vis forfatter(e) (2008). The effect of homocysteine-lowering B-vitamin intervention on angiographic coronary artery disease may be adverse - A WENBIT sub-study. Circulation. E334-E334.
  • Vis forfatter(e) (2008). Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery disease, a WENBIT substudy. Circulation. E487-E487.
  • Vis forfatter(e) (2008). Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study. Circulation. E472-E473.
  • Vis forfatter(e) (2008). Homocysteine and markers of immune activation as predictors of mortality in stable angina patients. Circulation. E351-E351.
  • Vis forfatter(e) (2008). B6 vitamers and long term mortality in patients with stable angina. Circulation. E347-E347.
  • Vis forfatter(e) (2008). Asymmetric and symmetric dimethylarginine are weaker predictors than homocysteine of long-term mortality in both men and women with stable angina. Circulation. E342-E342.
  • Vis forfatter(e) (2007). Predictors of plasma choline and betaine: The Hordaland Homocysteine Study. Clinical Chemistry and Laboratory Medicine. A18-A19.
  • Vis forfatter(e) (2005). The Effect of Homocysteine Lowering Therapy on Inflammatory Markers Neopterin and CRP in Patients with Stable Coronary Artery Disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). Haematalogica Reports. 66-66.
  • Vis forfatter(e) (2005). Effect of homocysteine lowering therapy on coronary endothelial function in patients with stable coronary artery disease. A substudy of the Western Norway B-vitamin Intervention Trial (WENBIT). European Heart Journal. 477-477.
  • Vis forfatter(e) (2005). Effect of Homocysteine Lowering Therapy on Coronary Endothelial Function in Patients with Stable Coronary Artery Disease. Haematalogica Reports. 10-10.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2015). The chromosome 9p21 CVD- and T2D-associated regions in a Norwegian population (the HUNT2 survey). International Journal of Endocrinology. 9 sider.
  • Vis forfatter(e) (2012). The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. Cardiology Research and Practice. 15 sider.
  • Vis forfatter(e) (2010). Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals. Archives of Internal Medicine. 1622-1631.
  • Vis forfatter(e) (2010). Circulating folate, vitamin B-12, homocysteine, vitamin B-12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiology, Biomarkers and Prevention. 1632-1642.

Se fullstendig oversikt over publikasjoner i CRIStin.